1. Home
  2. BIVI vs AHT Comparison

BIVI vs AHT Comparison

Compare BIVI & AHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • AHT
  • Stock Information
  • Founded
  • BIVI 2013
  • AHT 2003
  • Country
  • BIVI United States
  • AHT United States
  • Employees
  • BIVI N/A
  • AHT N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • AHT Real Estate Investment Trusts
  • Sector
  • BIVI Health Care
  • AHT Real Estate
  • Exchange
  • BIVI Nasdaq
  • AHT Nasdaq
  • Market Cap
  • BIVI 45.1M
  • AHT 49.3M
  • IPO Year
  • BIVI N/A
  • AHT 2003
  • Fundamental
  • Price
  • BIVI $3.05
  • AHT $9.32
  • Analyst Decision
  • BIVI Strong Buy
  • AHT Hold
  • Analyst Count
  • BIVI 2
  • AHT 1
  • Target Price
  • BIVI $40.00
  • AHT $25.00
  • AVG Volume (30 Days)
  • BIVI 3.2M
  • AHT 67.4K
  • Earning Date
  • BIVI 11-13-2024
  • AHT 11-05-2024
  • Dividend Yield
  • BIVI N/A
  • AHT N/A
  • EPS Growth
  • BIVI N/A
  • AHT N/A
  • EPS
  • BIVI N/A
  • AHT 1.83
  • Revenue
  • BIVI N/A
  • AHT $1,215,615,000.00
  • Revenue This Year
  • BIVI N/A
  • AHT N/A
  • Revenue Next Year
  • BIVI N/A
  • AHT N/A
  • P/E Ratio
  • BIVI N/A
  • AHT $5.07
  • Revenue Growth
  • BIVI N/A
  • AHT N/A
  • 52 Week Low
  • BIVI $1.04
  • AHT $5.20
  • 52 Week High
  • BIVI $56.54
  • AHT $24.80
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 54.95
  • AHT 59.51
  • Support Level
  • BIVI $3.00
  • AHT $7.52
  • Resistance Level
  • BIVI $3.85
  • AHT $9.69
  • Average True Range (ATR)
  • BIVI 0.38
  • AHT 1.22
  • MACD
  • BIVI -0.01
  • AHT 0.13
  • Stochastic Oscillator
  • BIVI 47.37
  • AHT 58.10

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About AHT Ashford Hospitality Trust Inc

Ashford Hospitality Trust Inc. is a real estate investment trust that invests in full-service upscale and upper-upscale hotel properties in the U.S. The company owns and operates its assets through its operating partnership, Ashford Hospitality Limited Partnership. All of its hotels are located across the U.S. and operate under the Marriott, Hilton, Hyatt, Crowne Plaza, and Sheraton brands. Ashford's sole segment is Direct Hotel Investments, through which it owns hotels by acquisition or development. Ashford also provides rest estate investment services, such as mezzanine financing, first mortgage financing, and sales-leaseback transactions. Its revenue streams include Room revenue, Food and beverage revenue, and Other revenue. Room revenue accounts for the majority of total revenue.

Share on Social Networks: